Outcome of Board Meeting dated 27-01-2025- Approval of Unaudited Financial Results (with limited review by auditors) of Third Qtr and First Nine Months ended 31/12/2025, Resignation of Directors & CSR Exp of FY 2024-25 approval etc.
Information related to Redemption of Entire Investment of Mutual Fund as on 15/01/2025 referred to information as per Regulations 30 of the SEBI (LODR)r DP Regulation 74(5) for the Quarter ended 31-12-2024
Disclosure of Quarterly Structural Digital Database Compliance of Reg.3(5) and 3(6) of SEBI (PIT) Regulations 2015 of Quarter ending 31st December, 2024
Notice of Board Meeting called on 27/01/2025 for approval of Unaudited Financial Results (with limited review by auditors) of Quarter/Nine Months ended 31/12/2024 and other Statutory Allied matters
Related Party Transaction Report as per Regulation 23(9) of First Half-year ended 30/09/2024 approved on Board Meeting dated 11-11-2024ated 11-11-2024- Approval of Unaudited Financial Results (with limited review by auditors) of Second Qtr and First Half Year ended 30/09/2024
Outcome of Board Meeting dated 11-11-2024- Approval of Unaudited Financial Results (with limited review by auditors) of Second Qtr and First Half Year ended 30/09/2024
Disclosure of Quarterly Structural Digital Database Compliance of Reg.3(5) and 3(6) of SEBI (PIT) Regulations 2015 of Quarter ending 30th September, 2024
Notice of Board Meeting called on 11/11/2024 for approval of Unaudited Financial Results (with limited review by auditors) of Quarter/Half Year ended 30/09/2024 and other Statutory Allied matters
Notice U/s.124(6) with List of unclaimed/unpaid dividend holders consecutive seven year from F.Y.2016-17 onwards – their shares to be transferred to IEPF Authorities A/c-Specimen Letter with Reply Copy.
Form : ISR-3 [Declaration Form for Opting-out of Nomination by holders of physical securities (if any)]of Signature of securities holders by the Banker]
Information asked to NON-KYC Dividend shareholders to update their KYC,PAN, Nomination etc. as per SEBI Circular Dated 07/05/2024 and attached Form ISR-1,2,3 SH-13 & 14 to filled and inform immediately
Information asked to Physical shareholders to update their KYC,PAN, Nomination etc. as per SEBI Circular Dated 07/05/2024 and attached Form ISR-1,2,3 SH-13 & 14 to filled and inform immediately
Outcome of Board Meeting dated 13-08-2024- Approval of Unaudited Financial Results (with limited review by auditors) of First Qtr ended 30/06/2024, appointment of new Chairman of all of its Four Committees w.e.f.13/08/2024
Notice of Board Meeting called on 13/08/2024 for approval of Unaudited Financial Results (with limited review by auditors) of Quarter ended 30/06/2024 and other Statutory Allied matters
Outcome of Board Meeting dated 27-05-2024- Approval of Audited Financial Results of 4th/Last Qtr ended and Annual Year Ended 31/03/2024, Recomendation of Final Dividend of FY 2023-24, Change of Statutory Auditors, Fixed 33rd AGM Notice, Agenda, venue etc.
Notice of Board Meeting called on 27/05/2024 for approval of Audited Financial Results of FY 2023-24 and Change of Auditors & other Statutory Allied matters
Outcome of Board Meeting dated 30-04-2024- Approval of Reappointment of Mr.Asheesh Dabriwal as Managing Director and Reappointment of Mr. Buddhadeb Basu & Dr.Subrata Haldar (Both) as Non-Executive Independent Director of the Company for a period of Five Years from 30-04-2024 to 29-04-2029 subject to approval of shareholders in ensuing AGM/EGM etc.ird Quarter and First Nine Months ended 31-12-2023 and approval of CSR Expenses of FY 2023-24 paid by way of Contribution to Prime Ministers National Relief Fund
Notice of Board Meeting called on 30/04/2024 for Reappointment of Managing Director & Reappointment of Two Nos Independent Directors & calling all Committee Meetings for Annual Closure 31/03/2024
Annual Submission of Certificate from Practicing Company Secretary U/r.40(9) & 61(4) of SEBI (LODR) for Share Transfer related of Year Ended 31st March, 2024
Outcome of Board Meeting dated 09-02-2024- Approval of Unaudited Financial Results (with limited review by auditors) of Third Quarter and First Nine Months ended 31-12-2023 and approval of CSR Expenses of FY 2023-24 paid by way of Contribution to Prime Ministers National Relief Fund
Disclosure of Quarterly Structural Digital Database Compliance of Reg.3(5) and 3(6) of SEBI (PIT) Regulations 2015 of Quarter ending 31st December, 2023
Notice of Board Meeting called on 09/02/2024 for approval of Unaudited Financial Results of 3rd Quarter & 1st Nine-Months Ended 31/12/2023 and approval of CSR Exp.of FY 2023-24 to be paid PMNRF
Outcome of Board Meeting dated 10-11-2023- Approval of Unaudited Financial Results (with limited review by auditors) of Second Quarter and First Half Year ended 30-09-2023 and Reconstitution of all its Four Committee2
Notice U/s.124(6) with List of unclaimed/unpaid dividend holders consecutive seven year from F.Y.2015-16 onwards – their shares to be transferred to IEPF Authorities A/c-Specimen Letter with Reply Copy.
Notice of Board Meeting called on 10/11/2023 for approval of Unaudited Financial Results of 2nd Quarter & 1st Half-year Ended 30/09/2023 and Re-structuring of all its Four Committee
Disclosure of Quarterly Structural Digital Database Compliance of Reg.3(5) and 3(6) of SEBI (PIT) Regulations 2015 of Quarter ending 30th September, 2023
Notice of 32nd Annual General Meeting to be held on 25/09/2023 for approval of Audited Accounts and Reports of YE 31/03/2023, approval of Final Dividend of FY 2022-23 and other Statutory allied Matters
Outcome of Board Meeting dated 10-08-2023- Approval of Unaudited Financial Results (with limited review by auditors) of QE 30/06/2023, approval of appointment of two nos Independent Directors and approval of Draft Notice of 32nd AGM etc.of year ended 31-03-2023 and other General and Statutory activities
Notice of Board Meeting called on 10/08/2023 for approval of Unaudited Financial Results of 1st Quarter Ended 30/06/2023 and appointment of two additional independent directors and finalisation of 32nd AGM Notice etc.
Information asked to Physical shareholders to update their KYC,PAN, Nomination etc. as per SEBI Circular Dated 16/03/2023 and attached Form ISR-1,2,3 SH-13 & 14 to filled and inform immediately
Outcome of Board Meeting dated 27-04-2023- Preparation of Finalisation of Accounts for the Purpose of various Audit of year ended 31-03-2023 and other General and Statutory activities
Outcome of Board Meeting dated 13-02-2023- Approval of Unaudited Financial Results (with limited review by auditors) of Third Quarter and First Nine Months ended 31-12-2022
Outcome of Board Meeting dated 30-05-2023- Approval of Audited Financial Results of Fourth Quarter and Annual Year Ended 31-03-2023 & Recommendation of Final Dividend of FY 2022-23
Notice of Board Meeting called on 30/05/2023 for approval of Audited Fourth Quarter and Audited Annual Year Ended Financial Results of Quarter/Year ended 31/03/2023
Annual Submission of Certificate from Practicing Company Secretary U/r.40(9) & 61(4) of SEBI (LODR) for Share Transfer related of Year Ended 31st march, 2023
Notice of Board Meeting called on 13/02/2023 for approval of Third Quarter and First Nine Months Ended Unaudited Financial Results (with limited review by auditors) of Quarter/Nine Months ended 31/12/2022 and appointment of two nos addl ind director & CSR Exp.
Outcome of Board Meeting dated 12-11-2022- Approval of Unaudited Financial Results (with limited review by auditors) of Second Quarter and First Half year ended 30-09-2022
Information asked to Physical shareholders to update their KYC,PAN, Nimination etc. as per SEBI Circular Dated 03/11/2021 & 14/12/2021 and attached Form ISR-1,2,3 SH-13 & 14 to filled and inform immediately
Submission of Draft Notice for publication & Newspaper Publication cutting as per recent MCA Rules & SEBI Circular for conducting AGM on 27-09-2021 at 11.00 AM as per Reg.30 & 47 of SEBI(LODR)
Notice U/s.124(6) with List of unclaimed/unpaid dividend holders consecutive seven year from F.Y.2014-15 onwards – their shares to be transferred to IEPF Authorities A/c-Specimen Letter with Reply Copy.
Disclosure of Post Acquisition Intimation received under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
